Literature DB >> 15138860

Transfusion of post-operative shed blood: laboratory characteristics and clinical utility.

M Muñoz1, J J García-Vallejo, M D Ruiz, R Romero, E Olalla, C Sebastián.   

Abstract

Increased awareness of the potential hazards of allogenic blood transfusion, such as incompatibility reactions, metabolic and immunologic disorders, or transmission of viral diseases, has led to an emphasis on allogeneic blood alternatives. For orthopaedic surgery, several autologous transfusion modalities have emerged as alternatives to allogeneic blood transfusion, avoiding its immunomodulatory effects. Among them, transfusion or return of post-operative salvaged shed blood has become popular in major orthopaedic procedures. However, although the effectiveness of this blood-saving method is well documented, several authors have questioned its safety and recommended the use of washed blood. Therefore, this review analyses the haematologic characteristics of unwashed filtered shed blood, including metabolic status and survival of red blood cells, the components of the haemostatic system, the content of fat particles, bacterial and tumour cells and the possibility of their removal, the content of inflammatory mediators, and the effects on the patient's immune system. From data reviewed in this paper, it can be concluded that post-operative salvage of blood seems to be an excellent source of functional and viable red cells without many of the transfusion-related risks and with some immuno-stimulatory effects. In addition, from our experience, post-operative re-infusion of unwashed shed blood after major spine procedures has proved to reduce post-operative homologous transfusion requirements and to complement pre-operative autologous blood donation, without any clinically relevant complication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138860      PMCID: PMC3592179          DOI: 10.1007/s00586-004-0718-0

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  59 in total

1.  Microrheology of filtered autotransfusion drain blood with and without leukocyte reduction.

Authors:  T Dalén; K G Engström
Journal:  Clin Hemorheol Microcirc       Date:  1999       Impact factor: 2.375

Review 2.  [Autotransfusion after orthopedic surgery. Analysis of quality, safety and efficacy of salvaged shed blood].

Authors:  M Muñoz Gómez; J García Vallejo; A López-Andrade Jurado; A Gómez Luque; M Ruiz Romero De La Cruz; J Maldonado Eloy-García
Journal:  Rev Esp Anestesiol Reanim       Date:  2001-03

Review 3.  Bloodless medicine: clinical care without allogeneic blood transfusion.

Authors:  Lawrence T Goodnough; Aryeh Shander; Richard Spence
Journal:  Transfusion       Date:  2003-05       Impact factor: 3.157

4.  Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients.

Authors:  P Perseghin; M Viganò; G Rocco; C Della Pona; A Buscemi; A Rizzi
Journal:  Vox Sang       Date:  1997       Impact factor: 2.144

5.  Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis.

Authors:  Gary E Hill; William H Frawley; Karl E Griffith; John E Forestner; Joseph P Minei
Journal:  J Trauma       Date:  2003-05

6.  Effect of autologous salvaged blood on postoperative natural killer cell precursor frequency.

Authors:  Ahmad Gharehbaghian; Kharaja M G Haque; Carol Truman; Rachel Evans; Ruth Morse; John Newman; Gordon Bannister; Chris Rogers; Benjamin A Bradley
Journal:  Lancet       Date:  2004-03-27       Impact factor: 79.321

7.  Unwashed filtered shed blood collected after knee and hip arthroplasties. A source of autologous red blood cells.

Authors:  P M Faris; M A Ritter; E M Keating; C R Valeri
Journal:  J Bone Joint Surg Am       Date:  1991-09       Impact factor: 5.284

8.  The role of autologous blood transfusion in adolescents undergoing spinal surgery.

Authors:  M M Moran; D Kroon; S J Tredwell; L D Wadsworth
Journal:  Spine (Phila Pa 1976)       Date:  1995-03-01       Impact factor: 3.468

9.  The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter.

Authors:  M J Edelman; P Potter; K G Mahaffey; R Frink; R B Leidich
Journal:  Urology       Date:  1996-02       Impact factor: 2.649

10.  Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients.

Authors:  Santiago R Leal-Noval; Irene Jara-López; José L García-Garmendia; Ana Marín-Niebla; Angel Herruzo-Avilés; Pedro Camacho-Laraña; Jesús Loscertales
Journal:  Anesthesiology       Date:  2003-04       Impact factor: 7.892

View more
  11 in total

Review 1.  Laboratory characteristics and clinical utility of post-operative cell salvage: washed or unwashed blood transfusion?

Authors:  Manuel Muñoz; Robert Slappendel; Dafydd Thomas
Journal:  Blood Transfus       Date:  2010-09-14       Impact factor: 3.443

2.  Unwashed shed blood: should we transfuse it?

Authors:  Giancarlo Maria Liumbruno; Jonathan H Waters
Journal:  Blood Transfus       Date:  2011-04-20       Impact factor: 3.443

3.  Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04-20       Impact factor: 3.443

4.  Intraoperative cell salvage versus postoperative autologous blood transfusion in hip arthroplasty: a retrospective service evaluation.

Authors:  L Mason; C Fitzgerald; J Powell-Tuck; R Rice
Journal:  Ann R Coll Surg Engl       Date:  2011-07       Impact factor: 1.891

Review 5.  The merits of cell salvage in arthroplasty surgery: an overview.

Authors:  Chris J Dusik; Carol Hutchison; David Langelier
Journal:  Can J Surg       Date:  2014-02       Impact factor: 2.089

6.  Does single use of an autologous transfusion system in TKA reduce the need for allogenic blood?: a prospective randomized trial.

Authors:  Johannes Cip; Mark Widemschek; Thomas Benesch; Roman Waibel; Arno Martin
Journal:  Clin Orthop Relat Res       Date:  2012-12-11       Impact factor: 4.176

7.  A cost study of postoperative cell salvage in the setting of elective primary hip and knee arthroplasty.

Authors:  Vidya K Rao; Robert Dyga; Christopher Bartels; Jonathan H Waters
Journal:  Transfusion       Date:  2012-02-17       Impact factor: 3.157

8.  Intraoperative cell salvage in revision hip surgery.

Authors:  J M Herd; J J Joseph; M McGarvey; P Tsimbouri; A Bennett; R M D Meek; A Morrison
Journal:  Ann Med Surg (Lond)       Date:  2014-01-22

Review 9.  Perioperative blood management strategies for patients undergoing total knee replacement: Where do we stand now?

Authors:  Tzatzairis Themistoklis; Vogiatzaki Theodosia; Kazakos Konstantinos; Drosos I Georgios
Journal:  World J Orthop       Date:  2017-06-18

10.  Postoperative autotransfusion drain after total hip arthroplasty: a meta-analysis of randomized controlled trials.

Authors:  Hui Xie; Jian-Ke Pan; Kun-Hao Hong; Da Guo; Jian Fang; Wei-Yi Yang; Jun Liu
Journal:  Sci Rep       Date:  2016-07-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.